This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier And The Nigerian Government Sign License Agreement To Expand Access To Scientific Information And Research Intelligence Tools

ADO EKITI, Nigeria, June 23, 2014 /PRNewswire/ --

Collaboration aims to enhance visibility and impact of Nigeria in global scientific community  

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced it has signed a licence agreement with the Nigerian Government providing continued access to ScienceDirect, Elsevier's full-text platform for research literature and Scopus, the largest abstract and citation database of peer-reviewed literature as well as access to SciVal, part of Elsevier's Research Intelligence portfolio of tools and services. 

The license agreement, signed by the Association of Vice-Chancellors of Nigerian Universities (AVCNU) on behalf of the Nigerian Government, provides researchers and faculty of a consortium of 79 government funded academic institutes with expanded access to peer-reviewed scholarly content. In addition, consortium members will benefit from access to research information management tools to measure the quality and impact of research, providing insights on how to raise Nigeria's visibility within the global scientific landscape. Finally, as part of the agreement Elsevier will produce and host a number of Nigerian journals to increase the journals' visibility and impact and offer consortium researchers with access to 14 biomedical journals from Cell Press.

Professor Michael Faborode, AVCNU's Secretary General, said: "Our collaboration with Elsevier fits the Government's aspiration to be a Top 20 world economy by the year 2020. Access to Elsevier's content and tools is an important step in delivering an information infrastructure necessary for growing Nigeria's R&D, a key step to achieve the 2020 vision. I'm confident this collaboration will increase our significance in the global research community."

Martijn van Baardwijk, Elsevier's Finance Director Research Solutions Sales, and representing Elsevier at the signing ceremony, commented, "We are pleased to continue our collaboration with the Nigerian research community and support them in all aspects of the research process: from doing the actual research through accessing high quality content, showcasing their research results and supporting research analysis and evaluation."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs